Pacira | PCRX - 债务

股票价格

22.60

每天变化

0.49 2.22%

每月一次

-3.46%

每年

-9.02%

Q1 预测

21.45

金融业

USD

USD 1.26B

现金及等价物

USD 158.55M

USD 54.62M

USD 547.97M

USD 120.59M

USD 372.19M

USD 3.19M

USD 38.71M

790

EPS每股收益

USD 0.06

股本和储备

USD 693.11M

USD 142.25M

债务利息支出

USD 3.89M

USD 8.53M

USD 372.19M

USD 1.03B

USD 1.64M

USD 193.68M

USD 3.19M

普通股股本

USD 41.12M

52.68

USD 9.52M

USD 196.87M

销售和管理费用

USD 91.87M

USD 152.86M

贸易债权人

USD 15.15M

应收帐款人

USD 124.07M

	债务	更改		日
Assertio Holdings	USD 38.87M		615K	2023-09
Astellas Pharma	JPY 831.43B		83.94B	2025-03
Bristol-Myers Squibb	USD 51.04B		112M	2025-09
Cara Therapeutics	USD 0		0	2025-03
Coherus Biosciences	USD 294.92M		1.25M	2025-03
Heron Therapeutics	USD 149.65M		157K	2024-09
Ironwood Pharmaceuticals	USD 583.99M		14.83M	2024-12
J&J	USD 45.8B		4.97B	2025-09
Ligand Pharmaceuticals	USD 451M		445.26M	2025-09
Nektar Therapeutics	USD 0		0	2022-06
Novo Nordisk	DKK 118.72B		61.75B	2025-03
Omeros	USD 442.16M		199K	2023-09
Pacira	USD 372.19M		4.53M	2025-12
Perrigo	USD 3.64B		7.2M	2025-09
Pfizer	USD 60.85B		78M	2025-09
Supernus Pharmaceuticals	USD 42.21M		10.44M	2025-09
Teva Pharmaceutical Industries	USD 17.07B		450M	2025-09
Xeris Pharmaceuticals	USD 257.65M		431K	2025-09
Xoma	USD 120.79M		3.27M	2024-06
Zoetis	USD 7.27B		482M	2025-09